Among these metabolites, glycine has been reported to reduce liver inflammation and ameliorate NAFLD by downregulating the TLR4 signaling pathway (Yang et al., 2017; Qu et al., 2023). Here, TLR4 is linked to metabolic dysfunction-associated steatotic liver disease.